The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Instagram Outage Disrupts Thousands of U.S. Users
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Thailand Inflation Remains Negative for 10th Straight Month in January
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 



